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Takayasu’s arteritis (TA) is a form of chronic vasculitis that typically occurs in young adult Asian females, but it can
also present in younger patients not fitting this classic profile. In these cases, the sequelae are generally similar to
those found in adults. The disease predominantly affects the aorta and its primary branches. However, the coronary
arteries are also affected in up to 20% of cases, which may precipitate myocardial infarction. Imaging of the
coronary arteries therefore becomes critically important in the evaluation of a patient with possible Takayasu’s
arteritis. We present a case of a pediatric patient with TA who had no symptoms of angina but who was found to
have significant coronary artery involvement on diagnostic imaging. This necessitated tailoring of traditional
management.
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Takayasu’s arteritis (TA) is a chronic vasculitis that pre-
dominantly affects the aorta, its main branches, and the
pulmonary arteries. Although it is the third most com-
mon vasculitis worldwide, the cause is largely unknown
[1,2]. The classic patient phenotype is an Asian woman
who is between 20 to 30 years old. It is relatively uncom-
mon in North America and Europe, with a female to
male predominance of 8.5:1. In pediatrics the disease
typically presents between the ages of 10 and 20 years
old, but it has presented as early as 24 months of age
[2]. The delay in diagnosis from initial disease manifest-
ation can be 2–11 years in adults and sometimes longer
in children [3].
In general, TA is viewed as having two phases, an
acute inflammatory phase and a chronic fibrotic phase.
The acute phase is characterized by a lymphocytic infil-
trate with occasional giant cells of the media and fibro-
blast proliferation causing thickening of the intima of
large vessels. Inflammation transitions to fibrosis during
the chronic phase. Elastic tissue in vessel walls is* Correspondence: kathryn.torok@chp.edu
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reproduction in any medium, provided the orreplaced by collagen resulting in thickening of all three
layers of the vessel. The intima may become rigid, and
aneurysmal formation can occur secondary to mural
stress on the vessel wall [3].
Although, the exact pathogenesis of TA is not well
understood, several lines of evidence support the im-
portant role of cellular autoimmunity [4]. The vaso
vasorum is thought to act as a gateway allowing the ac-
cumulation of cellular infiltrate into the vessel walls via
upregulation of cellular adhesion molecules and adventi-
tial neovascularisation [4]. The cellular infiltrate is char-
acterized by a mixture of lymphocytes, predominately
CD4+ T cells, dendritic cells, macrophages, giant cells
and B cells [5]. Pro-inflammatory T-cell cytokines, such
as TNF-α, IL-6 and IFN-γ, have been identified in the
peripheral circulation in TA patients, both expressed in
sera [6] and by peripheral blood mononuclear cells [7].
TNF-α is an important contributor to granuloma forma-
tion and has also been identified in aortic tissue of
patients with TA [8], therefore implicating TNF-α as a
possible therapeutic target.
Clinically, the early symptoms of the disease are non-
specific, including night sweats, anorexia, weight loss,
fatigue, myalgia, and arthritis. These symptoms can beLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Coronal (a) and Axial (b) CT Chest. Concentric wall
thickening at the origin of the major aortic arch branches: brachio-
cephalic trunk (thin white arrow) and left common carotid artery
origin (thick blue arrow).
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quent presentation in childhood is hypertension, fol-
lowed by headaches, fever, dyspnea, weight loss, and
vomiting [2]. Organ manifestations arise from reduced
blood supply due to vascular stenosis and subsequent
ischemia. Claudication and poor or absent arterial pulses
occur in areas of vessel involvement. The combination
of nonspecific symptoms with decreased/absent pulses
should raise suspicion for Takayasu’s arteritis, coined the
‘pulseless disease’.
The first report of coronary involvement with TA was
described in 1951 [9,10]. It has since been estimated that
10-20% of all Takayasu’s patients have coronary artery
involvement [3,9], based on autopsy and case series. One
large cohort study of 129 patients in Korea, with a mean
age of 29.5 years, found the prevalence of coronary ar-
tery involvement to be 23% (30 patients) between 1987
and 1991, when coronary arteriography was used to
screen patients without symptoms of angina [11]. This
series did not address the prognosis of patients with
asymptomatic coronary involvement, however coronary
ischemia is a recognized cause of death in these patients
that warrants aggressive treatment once found [10,12].
Even if immediate ischemia does not occur due to cor-
onary artery occlusion, vessels which have been inflamed
in systemic vasculitides, such as TA, show premature
atherosclerosis [12], placing patients at risk for myocar-
dial infarction.
Three types of coronary artery lesions have been
described pathologically. Type 1 is stenosis or occlusion
of the coronary ostia and the proximal segment of the
coronary arteries. Ostial stenosis occurs from extension
of the inflammation-induced intimal proliferation and
fibrous contraction from the ascending aorta and the
coronary ostia [10,13]. Type 2 is diffuse or focal coron-
ary arteritis, which can extend to all epicardial branches
or may involve focal segments (skip lesions). Type 3 is
the presence of coronary artery aneurysms. Type 1 is
believed to be the most common lesion, while types 2
and 3 are considered uncommon [9].
Once the diagnosis of TA is made, evaluation of the
extent of disease becomes important for management of
its complications. To our knowledge, there is little data
on the evaluation of pediatric TA patients for coronary
artery involvement and even less data on the manage-
ment of such patients. Because of the life threatening
complications of coronary artery involvement, a thor-
ough baseline evaluation should be performed, as the
medical and surgical options for repair depend on symp-
toms of ischemia and grade of lesions present [10,14].
Case presentation
A previously healthy 11 year old Caucasian boy was re-
ferred to pediatric rheumatology for recurrent febrileillnesses with anorexia, a 7 pound weight loss, and pro-
gressive fatigue for the past 11 months. His temperatures
were low grade (99-100 F). He had a history of night
sweats with muscle aches for a period of 4 weeks. Dur-
ing this time, he also developed vitiligo of the face. Fur-
ther review of systems did not reveal muscle weakness,
rash, joint pain, swelling, eye complaints, oral ulcers, or
Raynaud’s phenomenon. Family history was unremark-
able for any autoimmune or rheumatologic diseases.
Examination revealed a thin and fatigued but interactive
child with mild perioral vitiligo and tachycardia. He had no
bruits, but it was later noted that auscultation of the ca-
rotid pulse on the left was fainter in comparison to that on
the right. He was not hypertensive and four-extremity
blood pressures were not significantly different. Initial
studies included a general laboratory investigation, chest
X-ray, and ECG. This revealed an albumin of 3.2, total pro-
tein of 8.8, microcytic normochromic anemia, negative
fecal calprotectin, elevated sedimentation rate of 91 mm/h,
and C-reactive protein of 7.41 mg/dL. His IgG, IgA and
IgM levels were also elevated. A chest X-ray did not reveal
any cardiomegaly, masses, pulmonary infiltrates, or medi-
astinal adenopathy. The ECG revealed normal sinus
rhythm without any evidence of ventricular hypertrophy.
At this point, the differential diagnosis included
lymphoma, IBD, chronic deep tissue infection, occult
solid organ malignancy, vasculitis, and developing con-
nective tissue disease. Further investigation included a
whole body bone scan, which did not reveal any focal
uptake. A CT of his chest, abdomen, and pelvis was then
obtained, and this revealed concentric thickening of the
aortic arch with severe stenosis (approximately 70%) and
diffuse intimal thickening of the left common carotid
artery (LCCA). See Figure 1. Imaging of his abdomen
did not reveal any involvement of his renal arteries or
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with arteritis, and given the clinical context, he was diag-
nosed with Takayasu’s arteritis.
Treatment was initiated with pulse doses of IV methyl-
prednisolone while further evaluation was pursued. MRI
of the brain was normal and did not support any evi-
dence of cerebral ischemia secondary to the severe sten-
osis of the left common carotid artery or additional
vasculitis. Cardiology was consulted to assess for cardiac
ischemia, obtain a baseline echocardiogram, and provide
guidance on activity restriction.
His echocardiogram could not visualize his coronary
arteries well but did show a thickened and mildly dilated
ascending aorta and normal cardiac structure and biven-
tricular function. A CT angiogram with cardiac gating
using a beta blocker was performed to better visualize
the coronary arteries. See Figure 2. This revealed severe
stenosis (at least 95%) of the ostium of the right coron-
ary artery. The left coronary artery was approximately
50% stenosed and no collateral vessels were seen. Car-
diac enzymes and repeat ECG did not support any car-
diac ischemia. Cardiology recommended starting a daily
beta-blocker to decrease tachycardia and myocardial
oxygen demand, a statin to stabilize endothelium, and
aspirin to prevent coagulation. These medications will
be continued for the foreseeable future. Intense physical
activity restriction was also recommended until a
2 month follow-up cardiac gated CT angiogram and
stress treadmill test were performed.
He received 1000 mg IV solumedrol daily for 3 days.
He also received IV infliximab (10 mg/kg), initially every
2 weeks and then spaced to every 4 weeks. Anti-TNF
therapy was initiated because the patient was considered(a)
(b)
Figure 2 Coronal (a) and Axial (b) Cardiac Gated CT Chest. Fifty
percent narrowing of the origin of the left coronary artery is
demonstrated by arrow in (a, blue arrow). The right coronary artery
should also be visible in this coronal section but was not due to
stenosis (a). It can be seen as a wisp coming off the ascending aorta
in the axial image (b, red arrow).high risk for an MI or CVA due to the severe stenosis of
his coronary and carotid arteries. We were encouraged
by several case series of patients who responded well to
anti-TNF therapy, especially infliximab, after failing
other conventional therapies [15,16]. There were limited
case reports of the use of infliximab for pediatric TA
[17,18]. However, the pediatric case by N. Cakar et al.
[18] did experience regression of multiple arterial sten-
oses, including renal, superficial femoral, and carotid
arteries, after a year of infliximab treatment.
Soon after the initiation of therapy the patient
reported an increase in appetite and energy. His ESR
and CRP decreased to 7 mm/hr and <0.02 mg/dl re-
spectively after two weeks. His cardiology follow up was
reassuring at two months. A stress treadmill test was
performed using the Bruce Protocol for ten minutes. He
achieved 97% of his maximum heart rate with no ST-T
wave changes or arrhythmias. He had a normal heart
rate and blood pressure response. Subsequent imaging
(cardiac gated CTA and neck CTA) at 4 months from
his diagnosis showed marked improvement overall. See
Figure 3. There was notable reduction in the wall thick-
ening surrounding the ascending aorta, aortic arch, and
origins of the arch vessels, also the left coronary artery
stenosis opened up significantly (>50%); however the
right coronary artery remained severely narrowed at the
ostium and the left common carotid did show persistent
narrowing.
Conclusions
Few cases of childhood onset Takayasu’s arteritis have
demonstrated involvement of the coronary arteries
[13,19]. Review of the literature with adult onset Takaya-
su’s arteritis has shown that severe coronary involvement(a)
(b)
Figure 3 Coronal (a) and Axial (b) Cardiac Gated CT Chest
4 months after systemic therapy. The right coronary artery,
though still stenotic, was improved and now able to be visualized
on coronal section (a, thin red arrow). The left coronary artery
opened up significantly (b, blue arrow).
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our patient. Because these patients are at risk of serious
complications, such as death from a myocardial infarc-
tion, assessment of the degree of their disease becomes
paramount.
Echocardiography can yield important information
with regards to cardiac function, regional wall motion
abnormalities and valvar disease. While it is the initial
imaging modality of choice for children to assess coron-
ary artery anatomy in Kawasaki disease [20], it may be
insufficient for older children [21], as in our patient.
Patients with Kawasaki disease are typically younger and
have better acoustic windows to visualize the proximal
take-offs of the coronary arteries.
Due to the limitations of echocardiography, CT angi-
ography with cardiac gating was the recommended
modality for assessing our patient’s coronary arteries.
Thoracic CTA with retrospective gating offered the ben-
efits of assessing the degree of involvement in addition
to providing detailed anatomy of his coronary arteries. It
also facilitates motion-free evaluation of the heart, the
aorta, and great vessels in addition to the coronary arter-
ies [22]. In an adult series of patients with TA with chest
pain and/or dyspnea, multi-detector CT demonstrated a
high prevalence of coronary artery involvement (8 out of
18, 44%), with almost all coronary lesions being ostial or
proximal in location [23]. Those patients with coronary
artery involvement also had a longer disease duration
compared to those without.
Other radiologic modalities to access the vasculature
include conventional angiogram and MR angiogram. A
conventional angiogram, which profiles the vessels in
detail, is helpful when surgical intervention is necessary.
However, this procedure poses additional risks by acces-
sing large vessels, therefore it was deemed not necessary
in our patient’s case. MR angiogram offers the benefit of
no ionizing radiation. It is adequate and recommended
for following large arch vessels in chronic vasculitidies,
especially with the desire to decrease cumulative radi-
ation exposure. For the evaluation of stenosis of smaller
vessels, such as the coronary arteries, CT imaging is
better. After initial echocardiogram and CT studies
described, a baseline MR angiogram of the neck, chest
and abdomen was performed in our patient with plans
for regular MR angiogram monitoring (every 3–6 months),
in addition to less frequent cardiac gated CT angiogram
imaging for better coronary artery evaluation.
There is scant literature on the use of CT angiography
with cardiac gating for vasculitides. Our patient pre-
sented with a rare complication of pediatric TA that
required detailed imaging of his coronary arteries in
order to assess his risk of complications and guide ther-
apy and management. Thankfully, he did not show any
signs of ischemia or complications thereof but thishighlights an important step in the evaluation of patients
with TA for guiding management.
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